Fundraising Fox
Bedfont Scientific
Founded 1998 · 146 employees on LinkedIn · 1 known investors
Find your way into Bedfont Scientific
7 people in our graph share verified history with the Bedfont Scientific team — schools, employers, funds. One of them is your warm intro.
Chris Cornallunlockedknows Jason Smith · together at Canterbury Christ Church University (overlapped)
×6knows the team · via Canterbury Christ Church University
Bedfont manufactures non-invasive breath analysis medical devices, including the Smokerlyzer carbon monoxide monitor for smoking cessation, the NObreath FeNO device for asthma airway inflammation, and the Gastrolyzer range for gastrointestinal disorders and food intolerances. It also produces the Medi-gas Check range of portable monitors for verifying piped medical gas, and distributes through over 100 distributors worldwide.
Founders & leadership
JS
Jason SmithJason Smith is Managing Director of Bedfont Scientific, a manufacturer of exhaled breath and gas monitoring medical devices founded in 1976 and based in Kent. The company produces devices including carbon monoxide monitors for smoking cessation, FeNO monitors for asthma assessment, hydrogen and methane monitors for gastrointestinal diagnostics, and medical gas delivery systems.
Investors · 1
Keensight Capitallisted by Keensight CapitalParis · $10M – $800M
How we know: Keensight Capital's portfolio page · funding news · Not right? Tell us
In the news
Frequently asked questions
- What does Bedfont Scientific do?
- Bedfont manufactures non-invasive breath analysis medical devices, including the Smokerlyzer carbon monoxide monitor for smoking cessation, the NObreath FeNO device for asthma airway inflammation, and the Gastrolyzer range for gastrointestinal disorders and food intolerances. It also produces the Medi-gas Check range of portable monitors for verifying piped medical gas, and distributes through over 100 distributors worldwide.
- Who are Bedfont Scientific's investors?
- Bedfont Scientific's investors include Keensight Capital.